17
Participants
Start Date
September 23, 2021
Primary Completion Date
June 1, 2023
Study Completion Date
June 1, 2023
Locking Solution
The total duration of the study treatment period will be 90 calendar days, from Visit 1 Pre-Instillation to the last study-related assessment. Two to 3 instillations (1 per lumen per visit) of DuraLock-C 4.0%, 30.0%, or 46.7% (equivalent to the catheter manufacturer's prescribed priming volume) will be instilled 1 to 3 days apart (with a HD schedule of 3 to 4 times per week); each instillation of CLS will remain in the CVC for approximately 24 to 72 hours ± 12 hours, based on their practice preferences. EOS will take place at the patient's next scheduled dialysis session.
Clinique HEMERA Pays de Caux, 14 .A avenue Foch, Yvetot
Collaborators (2)
Syneos Health
OTHER
Veeva Systems
INDUSTRY
Medical Components, Inc dba MedComp
INDUSTRY